Built for the clinical and commercial manufacture of tablets and capsules, the 15,000 ft² facility in South Wales will enable Penn Pharma to improve on its heritage and varied services.
Penn Pharma CEO Richard Yarwood said that the company has built a world-class facility for contained manufacturing and produced the first batch of coated tablets.
Penn Pharma chief operating officer Mark Dean-Netscher said, "A facility of this complex nature was a tight build in the timeframe, but we have demonstrated that when Penn Pharma commits to something, we always deliver."